Page last updated: 2024-08-25

rosiglitazone and B-Cell Chronic Lymphocytic Leukemia

rosiglitazone has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolaman, Z; Kadikoylu, G; Karul, A; Sargin, G; Yavasoglu, I1

Other Studies

1 other study(ies) available for rosiglitazone and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
    Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:3

    Topics: ADP-ribosyl Cyclase 1; Annexin A5; Apoptosis; Atorvastatin; Calcium; CD5 Antigens; Female; Heptanoic Acids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphocytes; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Rosiglitazone; Thiazolidinediones; ZAP-70 Protein-Tyrosine Kinase

2013